Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 135

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 3
Chunk 135
---
                                         

As approved by our shareholders at the annual general meeting held
in 2022, our directors are entitled to cash compensation of $30,000 per annum, $1,200 for each board or committee meeting attended in
person, $720 for each board or committee meeting attended via telephone or videoconference, $600 for participation by written consent
and $3,000 for membership of each committee of the Board of Directors, and in the case of the Chairman of the Board of Directors, such
fees in amounts that are 50% higher than the foregoing fees, in each case provided that such fees do not exceed the maximum amounts payable
to external directors from time to time by us under the Israeli Companies Regulations (Rules Regarding Compensation and Expense Reimbursement
of External Directors), 2000 and the Israeli Companies Regulations (Relief for Companies whose Securities are Listed for Trading Outside
of Israel),2000. For theyear ended December 31, 2024, we recorded $62,300
on account of cash compensation paid to the Chairman of our Board of Directors, Dr. Aharon Schwartz, and a $6,400 equity-based compensation
expense for equity-based compensation granted to Dr. Schwartz.

74

For information concerning our equity compensation plan, see “ - Beneficial
Ownership of Executive Officers and Directors - Equity Compensation Plan. ”

There are currently no arrangements or understandings between us,
on the one hand, and any of our directors, on the other hand, providing for benefits upon termination of their service as directors of
our Company.

C. Board Practices

Board of Directors

According to the Companies Law, the management of our business
is vested in our board of directors. Our board of directors may exercise all powers and may take all actions that are not specifically
granted to our shareholders. Our executive officers are responsible for our day-to-day management and have individual responsibilities
established by our board of directors. Executive officers are appointed by and serve at the discretion of our board of directors, subject
to any applicable employment agreements we have entered into with the executive officers.

According to our Articles of Association, our board of directors
must consist of at least five and not more than 10 directors, including external directors under Israeli law (if any). Currently, our
board of directors consists of eight directors. Our board of directors has determined that each of our directors other than Mr. Yan
is an “independent director” under Nasdaq Listing Rules.

Under our Articles of Association,